Cargando…

Burden of Clostridium difficile Infections in Québec by Levy et al

Detalles Bibliográficos
Autores principales:	Longtin, Yves, Garenc, Christophe, Valiquette, Louis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942760/ https://www.ncbi.nlm.nih.gov/pubmed/27419192 http://dx.doi.org/10.1093/ofid/ofw139

Ejemplares similares

469. Validation and Characterization of Community-Acquired Clostridium difficile Infections from the Quebec C. difficile Infection Surveillance Program (QCISP)
por: Kazadi-Lukusa, Aimé, et al.
Publicado: (2018)

477. Trends in the Incidence of Community-Associated and Healthcare-Associated Clostridium difficile Infections in Quebec Over a 7-Year Period (2008–2015)
por: Zanichelli, Veronica, et al.
Publicado: (2018)

Increased Community-Associated Clostridioides difficile Infections in Quebec, Canada, 2008–2015
por: Zanichelli, Veronica, et al.
Publicado: (2020)

525 Epidemiology and burden of recurrent Clostridium difficile infections
por: Sheitoyan-Pesant, Caroline, et al.
Publicado: (2014)

Prediction Tools for Unfavourable Outcomes in Clostridium difficile Infection: A Systematic Review
por: Abou Chakra, Claire Nour, et al.
Publicado: (2012)

190 Adequacy of Prior Antibiotic Use in Patients with Clostridium difficile Infection: A Resptrospective Analysis
por: Lam, Stefanie, et al.
Publicado: (2014)

Reply to Levis and Rendini
por: Singh, Dhiraj Kumar, et al.
Publicado: (2017)

Risk Factors for Recurrence, Complications and Mortality in Clostridium difficile Infection: A Systematic Review
por: Abou Chakra, Claire Nour, et al.
Publicado: (2014)

Fidaxomicin versus Vancomycin in the Treatment of Clostridium difficile Infection: Canadian Outcomes
por: Lee, Christine, et al.
Publicado: (2016)

Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection
por: Gonzales, Milagros, et al.
Publicado: (2010)

748. The Changing Epidemiology of Clostridioides difficile Infection and the NAP1/027 Strain in Two Quebec Hospitals
por: Couture, Sandrine, et al.
Publicado: (2021)

Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam
por: Garneau, Julian R, et al.
Publicado: (2014)

Fecal Microbiota Transplantation by Freeze-Dried Oral Capsules for Recurrent Clostridium difficile Infection
por: Hecker, Michelle T., et al.
Publicado: (2016)

LIPE C-60G influences the effects of physical activity on body fat and plasma lipid concentrations: the Quebec Family Study
por: Garenc, Christophe, et al.
Publicado: (2009)

Clostridium difficile Enteritis With NAP7/078 Toxigenic Strain
por: Zewude, Rahel T, et al.
Publicado: (2023)

The Epidemiology and Economic Burden of Clostridium difficile Infection in Korea
por: Choi, Hyung-Yun, et al.
Publicado: (2015)

Burden of Clostridium difficile on the Healthcare System
por: Dubberke, Erik R., et al.
Publicado: (2012)

External validation of predictive scores for mortality following Clostridium difficile infection
por: Beauregard-Paultre, Catherine, et al.
Publicado: (2017)

External validation of clinical scores to predict complications of Clostridium difficile infection
por: Beauregard-Paultre, Catherine, et al.
Publicado: (2017)

Erratum for Boudry et al., Function of the CRISPR-Cas System of the Human Pathogen Clostridium difficile
por: Boudry, Pierre, et al.
Publicado: (2015)

Clostridium difficile Infection
por: Feuerstadt, Paul
Publicado: (2015)

Clostridium difficile infection
por: Geller, Stephen A., et al.
Publicado: (2014)

Clostridium difficile Infection
por: Magdesian, K. Gary
Publicado: (2003)

Cryobiopsy Compared with Surgical Lung Biopsy in ILD: Reply to Maldonado et al., Froidure et al., Bendstrup et al., Agarwal et al., Richeldi et al., Rajchgot et al., and Quadrelli et al.
por: Romagnoli, Micaela, et al.
Publicado: (2019)

Impact of sink location on hand hygiene compliance after care of patients with Clostridium difficile infection: a cross-sectional study
por: Deyneko, Alexander, et al.
Publicado: (2016)

Reply to Thysen et al
por: Tchakoute, Christophe Toukam, et al.
Publicado: (2015)

699. Clinical Outcomes and Management of NAAT-Positive/Toxin-Negative Clostridium difficile Infection: A Systematic Review and Meta-Analysis
por: Prosty, Connor, et al.
Publicado: (2023)

Evaluation of the Xpert Clostridium difficile Assay for the Diagnosis of Clostridium difficile Infection
por: Shin, Saeam, et al.
Publicado: (2012)

Reply by Gattinoni et al. to Hedenstierna et al., to Maley et al., to Fowler et al., to Bhatia and Mohammed, to Bos, to Koumbourlis and Motoyama, and to Haouzi et al.
por: Gattinoni, Luciano, et al.
Publicado: (2020)

Characteristics of Clostridium difficile isolates and the burden of hospital-acquired Clostridium difficile infection in a tertiary teaching hospital in Chongqing, Southwest China
por: Dai, Wei, et al.
Publicado: (2020)

Reply to Cottin et al., to Johannson et al., to Scholand and Wells, and to Crowley et al.
por: Raghu, Ganesh, et al.
Publicado: (2022)

Reply to Lescoat et al. and to Khamis et al.
por: Adegunsoye, Ayodeji, et al.
Publicado: (2019)

Reply to Chase et al. and to Milner et al.
por: Mittel, Aaron M., et al.
Publicado: (2020)

Reply by Xu et al. to Haouzi et al.
por: Xu, Yonghao, et al.
Publicado: (2020)

Reply by Pan et al. to Haouzi et al.
por: Pan, Chun, et al.
Publicado: (2020)

Reply to Topeli et al. and to Akinosoglou et al.
por: Azevedo, Luciano C. P., et al.
Publicado: (2020)

Reply to Turnbull et al. and to Hulme et al.
por: Breuer, Oded, et al.
Publicado: (2020)

Reply to Shoemark et al. and to Shapiro et al.
por: Amirav, Israel, et al.
Publicado: (2020)

Reply to Gueret et al. and to Hammond et al.
por: Brown, Ryan M., et al.
Publicado: (2020)

Reply to Blot et al. and to Inoue et al.
por: McElvaney, Oliver J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mtthc9nalrvjopivccilveggbr